Stockreport

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

Standard BioTools Inc.  (LAB) 
PDF BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced preliminary and unaudited revenue [Read more]